 |
| Uterine Fibroid Treatment Market |
The global uterine fibroid treatment market
is witnessing considerable growth due to increasing female geriatric
population, increasing healthcare expenditure, increasing prevalence of
obesity, launch of technologically advanced fibroid treatment products and
growing popularity of minimally invasive treatments. Moreover, growing
prevalence of hormonal disorders or hormonal imbalance leading to fibroid
formation is supporting the growth of the market. The increasing adoption of
uterine fibroid treatment across the globe, owing to increasing incidence of
cancer is also driving the growth of the market.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/uterine-fibroid-treatment-market/report-sample
As reported by UNDESA (United Nation Department of Economic and Social
Affairs) in the year 2013, the elder population is predominantly female. As
women tend to live longer than men, while older women have outnumbered older
men almost everywhere in the world. It further reported that in the year 2013,
globally there were 85 men per 100 women in the age group 60 years or plus; and
61 men per 100 women in the age group 80 years or plus. The elderly population
is more susceptible to gynecological problems, such as abnormal uterine
bleeding, hormonal imbalance, and irregular menstrual cycle as compared to
adults, which is fueling the demand of the global fibroid treatment market.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/uterine-fibroid-treatment-market
Geographically, North America has been the largest market for uterine
fibroid treatment, owing to its increased awareness, established healthcare
industry, and easy accessibility to advanced technologies due to the presence
of high number of hospitals, clinics and ambulatory surgical centers in the
region. The U.S. contributed largest revenue to the North American as well as
global uterine fibroid treatment market. The increased patient pool undergoing
hormonal disorders and increasing prevalence of uterine cancer is the key
growth driving factor for the U.S. uterine fibroid treatment market.
Europe has been the second largest market for uterine fibroid treatment,
where the market is driven by the presence of a large pool of uterine cancer
patients, increasing healthcare expenditure and rapidly developing healthcare
infrastructure. In 2015, Germany lead the European uterine fibroid treatment
market and it is also expected to grow at the fastest rate in Europe, during
the forecast period. Globally, the uterine fibroid treatment market is expected
to witness the fastest growth in Asia-Pacific during the forecast period. The
highest growth in the region is attributed to the increasing prevalent cases
with abnormal uterine bleeding, irregular menstrual cycle, increasing per
capita income leading to improved standard of living, increasing healthcare
spending, growing demand for better quality medical care, and awareness about
uterine fibroid treatment in the region.
Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=uterine-fibroid-treatment-market
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research-based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
No comments:
Post a Comment